利用表面等离子体共振研究构象疾病中蛋白质的相互作用:新治疗视角的实验方法

Lee, V.M.Y.; Goedert, M.; Trojanowski, J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci., 2001, 24(1), 1121-1159.
[http://dx.doi.org/10.1146/annurev.neuro.24.1.1121] [PMID: 11520930]

Dickson, D.W.; Kouri, N.; Murray, M.E.; Josephs, K.A. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J. Mol. Neurosci., 2011, 45(3), 384-389.
[http://dx.doi.org/10.1007/s12031-011-9589-0] [PMID: 21720721]

Spillantini, M.G.; Goedert, M. Tau pathology and neurodegeneration. Lancet Neurol., 2013, 12(6), 609-622.
[http://dx.doi.org/10.1016/S1474-4422(13)70090-5] [PMID: 23684085]

Kovacs, G.G. Invited review: Neuropathology of tauopathies: Principles and practice. Neuropathol. Appl. Neurobiol., 2015, 41(1), 3-23.
[http://dx.doi.org/10.1111/nan.12208] [PMID: 25495175]

Uéda, K.; Fukushima, H.; Masliah, E.; Xia, Y.; Iwai, A.; Yoshimoto, M.; Otero, D.A.; Kondo, J.; Ihara, Y.; Saitoh, T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA, 1993, 90(23), 11282-11286.
[http://dx.doi.org/10.1073/pnas.90.23.11282] [PMID: 8248242]

Glenner, G.G.; Wong, C.W. Alzheimer’s disease and Down’s syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun., 1984, 122(3), 1131-1135.
[http://dx.doi.org/10.1016/0006-291X(84)91209-9] [PMID: 6236805]

Glenner, G.G.; Wong, C.W. Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun., 1984, 120(3), 885-890.
[http://dx.doi.org/10.1016/S0006-291X(84)80190-4] [PMID: 6375662]

Brion, J.P.; Couck, A.M.; Passareiro, E.; Flament-Durand, J. Neurofibrillary tangles of Alzheimer’s disease: An immunohistochemical study. J. Submicrosc. Cytol., 1985, 17(1), 89-96.
[PMID: 3973960]

Grundke-Iqbal, I.; Iqbal, K.; Tung, Y.C.; Quinlan, M.; Wisniewski, H.M.; Binder, L.I. Abnormal phosphorylation of the microtubule-associated protein (tau ) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA, 1986, 83(13), 4913-4917.
[http://dx.doi.org/10.1073/pnas.83.13.4913] [PMID: 3088567]

Kosik, K.S.; Joachim, C.L.; Selkoe, D.J. Microtubule-associated protein tau is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA, 1986, 83(11), 4044-4048.
[http://dx.doi.org/10.1073/pnas.83.11.4044] [PMID: 2424016]

Pollock, N.; Mirra, S.; Binder, L.; Hansen, L.; Wood, J. Filamentous aggregates in Pick’s disease, progressive supranuclear palsy, and Alzheimer’s disease share antigenic determinants with microtubule-associated protein, tau . Lancet, 1986, 328(8517), 1211.
[http://dx.doi.org/10.1016/S0140-6736(86)92212-9] [PMID: 2430155]

Selkoe, D.J. Alzheimer disease: Mechanistic understanding predicts novel therapies. Ann. Intern. Med., 2004, 140(8), 627-638.
[http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00047] [PMID: 15096334]

Querfurth, H.W.; LaFerla, F.M. Alzheimer’s disease. N. Engl. J. Med., 2010, 362(4), 329-344.
[http://dx.doi.org/10.1056/NEJMra0909142] [PMID: 20107219]

Liu, Y.; Vollrath, D. Reversal of mutant myocilin non-secretion and cell killing: Implications for glaucoma. Hum. Mol. Genet., 2004, 13(11), 1193-1204.
[http://dx.doi.org/10.1093/hmg/ddh128] [PMID: 15069026]

Guo, L.; Salt, T.E.; Luong, V.; Wood, N.; Cheung, W.; Maass, A.; Ferrari, G.; Russo-Marie, F.; Sillito, A.M.; Cheetham, M.E.; Moss, S.E.; Fitzke, F.W.; Cordeiro, M.F. Targeting amyloid-β in glaucoma treatment. Proc. Natl. Acad. Sci. USA, 2007, 104(33), 13444-13449.
[http://dx.doi.org/10.1073/pnas.0703707104] [PMID: 17684098]

McLean, C.A.; Cherny, R.A.; Fraser, F.W.; Fuller, S.J.; Smith, M.J.; Konrad Vbeyreuther; Bush, A.I.; Masters, C.L. Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann. Neurol., 1999, 46(6), 860-866.
[http://dx.doi.org/10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M] [PMID: 10589538]

Grasso, G.; Bonnet, S. Metal complexes and metalloproteases: Targeting conformational diseases. Metallomics, 2014, 6(8), 1346-1357.
[http://dx.doi.org/10.1039/C4MT00076E] [PMID: 24870829]

Harris, M.E.; Hensley, K.; Butterfield, D.A.; Leedle, R.A.; Carney, J.M. Direct evidence of oxidative injury produced by the Alzheimer’s β-Amyloid peptide (1–40) in cultured hippocampal neurons. Exp. Neurol., 1995, 131(2), 193-202.
[http://dx.doi.org/10.1016/0014-4886(95)90041-1] [PMID: 7895820]

Kumar, D.K.V.; Choi, S.H.; Washicosky, K.J.; Eimer, W.A.; Tucker, S.; Ghofrani, J.; Lefkowitz, A.; McColl, G.; Goldstein, L.E.; Tanzi, R.E.; Moir, R.D. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci. Transl. Med., 2016, 8(340), 340ra72.
[http://dx.doi.org/10.1126/scitranslmed.aaf1059] [PMID: 27225182]

Kunkle, B.W.; Grenier-Boley, B.; Sims, R.; Bis, J.C.; Damotte, V.; Naj, A.C.; Boland, A.; Vronskaya, M.; van der Lee, S.J.; Amlie-Wolf, A.; Bellenguez, C.; Frizatti, A.; Chouraki, V.; Martin, E.R.; Sleegers, K.; Badarinarayan, N.; Jakobsdottir, J.; Hamilton-Nelson, K.L.; Moreno-Grau, S.; Olaso, R.; Raybould, R.; Chen, Y.; Kuzma, A.B.; Hiltunen, M.; Morgan, T.; Ahmad, S.; Vardarajan, B.N.; Epelbaum, J.; Hoffmann, P.; Boada, M.; Beecham, G.W.; Garnier, J-G.; Harold, D.; Fitzpatrick, A.L.; Valladares, O.; Moutet, M-L.; Gerrish, A.; Smith, A.V.; Qu, L.; Bacq, D.; Denning, N.; Jian, X.; Zhao, Y.; Del Zompo, M.; Fox, N.C.; Choi, S-H.; Mateo, I.; Hughes, J.T.; Adams, H.H.; Malamon, J.; Sanchez-Garcia, F.; Patel, Y.; Brody, J.A.; Dombroski, B.A.; Naranjo, M.C.D.; Daniilidou, M.; Eiriksdottir, G.; Mukherjee, S.; Wallon, D.; Uphill, J.; Aspelund, T.; Cantwell, L.B.; Garzia, F.; Galimberti, D.; Hofer, E.; Butkiewicz, M.; Fin, B.; Scarpini, E.; Sarnowski, C.; Bush, W.S.; Meslage, S.; Kornhuber, J.; White, C.C.; Song, Y.; Barber, R.C.; Engelborghs, S.; Sordon, S.; Voijnovic, D.; Adams, P.M.; Vandenberghe, R.; Mayhaus, M.; Cupples, L.A.; Albert, M.S.; De Deyn, P.P.; Gu, W.; Himali, J.J.; Beekly, D.; Squassina, A.; Hartmann, A.M.; Orellana, A.; Blacker, D.; Rodriguez-Rodriguez, E.; Lovestone, S.; Garcia, M.E.; Doody, R.S.; Munoz-Fernadez, C.; Sussams, R.; Lin, H.; Fairchild, T.J.; Benito, Y.A.; Holmes, C.; Karamujić-Čomić, H.; Frosch, M.P.; Thonberg, H.; Maier, W.; Roshchupkin, G.; Ghetti, B.; Giedraitis, V.; Kawalia, A.; Li, S.; Huebinger, R.M.; Kilander, L.; Moebus, S.; Hernández, I.; Kamboh, M.I.; Brundin, R.; Turton, J.; Yang, Q.; Katz, M.J.; Concari, L.; Lord, J.; Beiser, A.S.; Keene, C.D.; Helisalmi, S.; Kloszewska, I.; Kukull, W.A.; Koivisto, A.M.; Lynch, A.; Tarraga, L.; Larson, E.B.; Haapasalo, A.; Lawlor, B.; Mosley, T.H.; Lipton, R.B.; Solfrizzi, V.; Gill, M.; Longstreth, W.T., Jr; Montine, T.J.; Frisardi, V.; Diez-Fairen, M.; Rivadeneira, F.; Petersen, R.C.; Deramecourt, V.; Alvarez, I.; Salani, F.; Ciaramella, A.; Boerwinkle, E.; Reiman, E.M.; Fievet, N.; Rotter, J.I.; Reisch, J.S.; Hanon, O.; Cupidi, C.; Andre Uitterlinden, A.G.; Royall, D.R.; Dufouil, C.; Maletta, R.G.; de Rojas, I.; Sano, M.; Brice, A.; Cecchetti, R.; George-Hyslop, P.S.; Ritchie, K.; Tsolaki, M.; Tsuang, D.W.; Dubois, B.; Craig, D.; Wu, C-K.; Soininen, H.; Avramidou, D.; Albin, R.L.; Fratiglioni, L.; Germanou, A.; Apostolova, L.G.; Keller, L.; Koutroumani, M.; Arnold, S.E.; Panza, F.; Gkatzima, O.; Asthana, S.; Hannequin, D.; Whitehead, P.; Atwood, C.S.; Caffarra, P.; Hampel, H.; Quintela, I.; Carracedo, Á.; Lannfelt, L.; Rubinsztein, D.C.; Barnes, L.L.; Pasquier, F.; Frölich, L.; Barral, S.; McGuinness, B.; Beach, T.G.; Johnston, J.A.; Becker, J.T.; Passmore, P.; Bigio, E.H.; Schott, J.M.; Bird, T.D.; Warren, J.D.; Boeve, B.F.; Lupton, M.K.; Bowen, J.D.; Proitsi, P.; Boxer, A.; Powell, J.F.; Burke, J.R.; Kauwe, J.S.K.; Burns, J.M.; Mancuso, M.; Buxbaum, J.D.; Bonuccelli, U.; Cairns, N.J.; McQuillin, A.; Cao, C.; Livingston, G.; Carlson, C.S.; Bass, N.J.; Carlsson, C.M.; Hardy, J.; Carney, R.M.; Bras, J.; Carrasquillo, M.M.; Guerreiro, R.; Allen, M.; Chui, H.C.; Fisher, E.; Masullo, C.; Crocco, E.A.; DeCarli, C.; Bisceglio, G.; Dick, M.; Ma, L.; Duara, R.; Graff-Radford, N.R.; Evans, D.A.; Hodges, A.; Faber, K.M.; Scherer, M.; Fallon, K.B.; Riemenschneider, M.; Fardo, D.W.; Heun, R.; Farlow, M.R.; Kölsch, H.; Ferris, S.; Leber, M.; Foroud, T.M.; Heuser, I.; Galasko, D.R.; Giegling, I.; Gearing, M.; Hüll, M.; Geschwind, D.H.; Gilbert, J.R.; Morris, J.; Green, R.C.; Mayo, K.; Growdon, J.H.; Feulner, T.; Hamilton, R.L.; Harrell, L.E.; Drichel, D.; Honig, L.S.; Cushion, T.D.; Huentelman, M.J.; Hollingworth, P.; Hulette, C.M.; Hyman, B.T.; Marshall, R.; Jarvik, G.P.; Meggy, A.; Abner, E.; Menzies, G.E.; Jin, L-W.; Leonenko, G.; Real, L.M.; Jun, G.R.; Baldwin, C.T.; Grozeva, D.; Karydas, A.; Russo, G.; Kaye, J.A.; Kim, R.; Jessen, F.; Kowall, N.W.; Vellas, B.; Kramer, J.H.; Vardy, E.; LaFerla, F.M.; Jöckel, K-H.; Lah, J.J.; Dichgans, M.; Leverenz, J.B.; Mann, D.; Levey, A.I.; Pickering-Brown, S.; Lieberman, A.P.; Klopp, N.; Lunetta, K.L.; Wichmann, H-E.; Lyketsos, C.G.; Morgan, K.; Marson, D.C.; Brown, K.; Martiniuk, F.; Medway, C.; Mash, D.C.; Nöthen, M.M.; Masliah, E.; Hooper, N.M.; McCormick, W.C.; Daniele, A.; McCurry, S.M.; Bayer, A.; McDavid, A.N.; Gallacher, J.; McKee, A.C.; van den Bussche, H.; Mesulam, M.; Brayne, C.; Miller, B.L.; Riedel-Heller, S.; Miller, C.A.; Miller, J.W.; Al-Chalabi, A.; Morris, J.C.; Shaw, C.E.; Myers, A.J.; Wiltfang, J.; O’Bryant, S.; Olichney, J.M.; Alvarez, V.; Parisi, J.E.; Singleton, A.B.; Paulson, H.L.; Collinge, J.; Perry, W.R.; Mead, S.; Peskind, E.; Cribbs, D.H.; Rossor, M.; Pierce, A.; Ryan, N.S.; Poon, W.W.; Nacmias, B.; Potter, H.; Sorbi, S.; Quinn, J.F.; Sacchinelli, E.; Raj, A.; Spalletta, G.; Raskind, M.; Caltagirone, C.; Bossù, P.; Orfei, M.D.; Reisberg, B.; Clarke, R.; Reitz, C.; Smith, A.D.; Ringman, J.M.; Warden, D.; Roberson, E.D.; Wilcock, G.; Rogaeva, E.; Bruni, A.C.; Rosen, H.J.; Gallo, M.; Rosenberg, R.N.; Ben-Shlomo, Y.; Sager, M.A.; Mecocci, P.; Saykin, A.J.; Pastor, P.; Cuccaro, M.L.; Vance, J.M.; Schneider, J.A.; Schneider, L.S.; Slifer, S.; Seeley, W.W.; Smith, A.G.; Sonnen, J.A.; Spina, S.; Stern, R.A.; Swerdlow, R.H.; Tang, M.; Tanzi, R.E.; Trojanowski, J.Q.; Troncoso, J.C.; Van Deerlin, V.M.; Van Eldik, L.J.; Vinters, H.V.; Vonsattel, J.P.; Weintraub, S.; Welsh-Bohmer, K.A.; Wilhelmsen, K.C.; Williamson, J.; Wingo, T.S.; Woltjer, R.L.; Wright, C.B.; Yu, C-E.; Yu, L.; Saba, Y.; Pilotto, A.; Bullido, M.J.; Peters, O.; Crane, P.K.; Bennett, D.; Bosco, P.; Coto, E.; Boccardi, V.; De Jager, P.L.; Lleo, A.; Warner, N.; Lopez, O.L.; Ingelsson, M.; Deloukas, P.; Cruchaga, C.; Graff, C.; Gwilliam, R.; Fornage, M.; Goate, A.M.; Sanchez-Juan, P.; Kehoe, P.G.; Amin, N.; Ertekin-Taner, N.; Berr, C.; Debette, S.; Love, S.; Launer, L.J.; Younkin, S.G.; Dartigues, J-F.; Corcoran, C.; Ikram, M.A.; Dickson, D.W.; Nicolas, G.; Campion, D.; Tschanz, J.; Schmidt, H.; Hakonarson, H.; Clarimon, J.; Munger, R.; Schmidt, R.; Farrer, L.A.; Van Broeckhoven, C.; C O’Donovan, M.; DeStefano, A.L.; Jones, L.; Haines, J.L.; Deleuze, J.F.; Owen, M.J.; Gudnason, V.; Mayeux, R.; Escott-Price, V.; Psaty, B.M.; Ramirez, A.; Wang, L.S.; Ruiz, A.; van Duijn, C.M.; Holmans, P.A.; Seshadri, S.; Williams, J.; Amouyel, P.; Schellenberg, G.D.; Lambert, J.C.; Pericak-Vance, M.A. Alzheimer Disease Genetics Consortium (ADGC)European Alzheimer’s Disease Initiative (EADI)Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE). Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES). Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau , immunity and lipid processing. Nat. Genet., 2019, 51(3), 414-430.
[http://dx.doi.org/10.1038/s41588-019-0358-2] [PMID: 30820047]

Bis, J.C.; Jian, X.; Kunkle, B.W.; Chen, Y.; Hamilton-Nelson, K.L.; Bush, W.S.; Salerno, W.J.; Lancour, D.; Ma, Y.; Renton, A.E.; Marcora, E.; Farrell, J.J.; Zhao, Y.; Qu, L.; Ahmad, S.; Amin, N.; Amouyel, P.; Beecham, G.W.; Below, J.E.; Campion, D.; Cantwell, L.; Charbonnier, C.; Chung, J.; Crane, P.K.; Cruchaga, C.; Cupples, L.A.; Dartigues, J.F.; Debette, S.; Deleuze, J.F.; Fulton, L.; Gabriel, S.B.; Genin, E.; Gibbs, R.A.; Goate, A.; Grenier-Boley, B.; Gupta, N.; Haines, J.L.; Havulinna, A.S.; Helisalmi, S.; Hiltunen, M.; Howrigan, D.P.; Ikram, M.A.; Kaprio, J.; Konrad, J.; Kuzma, A.; Lander, E.S.; Lathrop, M.; Lehtimäki, T.; Lin, H.; Mattila, K.; Mayeux, R.; Muzny, D.M.; Nasser, W.; Neale, B.; Nho, K.; Nicolas, G.; Patel, D.; Pericak-Vance, M.A.; Perola, M.; Psaty, B.M.; Quenez, O.; Rajabli, F.; Redon, R.; Reitz, C.; Remes, A.M.; Salomaa, V.; Sarnowski, C.; Schmidt, H.; Schmidt, M.; Schmidt, R.; Soininen, H.; Thornton, T.A.; Tosto, G.; Tzourio, C.; van der Lee, S.J.; van Duijn, C.M.; Valladares, O.; Vardarajan, B.; Wang, L.S.; Wang, W.; Wijsman, E.; Wilson, R.K.; Witten, D.; Worley, K.C.; Zhang, X.; Bellenguez, C.; Lambert, J.C.; Kurki, M.I.; Palotie, A.; Daly, M.; Boerwinkle, E.; Lunetta, K.L.; Destefano, A.L.; Dupuis, J.; Martin, E.R.; Schellenberg, G.D.; Seshadri, S.; Naj, A.C.; Fornage, M.; Farrer, L.A. Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation. Mol. Psychiatry, 2020, 25(8), 1859-1875.
[http://dx.doi.org/10.1038/s41380-018-0112-7] [PMID: 30108311]

Jang, S.S.; Chung, H.J. Emerging link between alzheimer’s disease and homeostatic synaptic plasticity. Neural Plast., 2016, 2016, 7969272.
[http://dx.doi.org/10.1155/2016/7969272] [PMID: 27019755]

Stellwagen, D.; Malenka, R.C. Synaptic scaling mediated by glial TNF-α. Nature, 2006, 440(7087), 1054-1059.
[http://dx.doi.org/10.1038/nature04671] [PMID: 16547515]

Trapp, B.D.; Wujek, J.R.; Criste, G.A.; Jalabi, W.; Yin, X.; Kidd, G.J.; Stohlman, S.; Ransohoff, R. Evidence for synaptic stripping by cortical microglia. Glia, 2007, 55(4), 360-368.
[http://dx.doi.org/10.1002/glia.20462] [PMID: 17136771]

Henstridge, C.M.; Tzioras, M.; Paolicelli, R.C. Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration. Front. Cell. Neurosci., 2019, 13, 63.
[http://dx.doi.org/10.3389/fncel.2019.00063] [PMID: 30863284]

Sala Frigerio, C.; Wolfs, L.; Fattorelli, N.; Thrupp, N.; Voytyuk, I.; Schmidt, I.; Mancuso, R.; Chen, W.T.; Woodbury, M.E.; Srivastava, G.; Möller, T.; Hudry, E.; Das, S.; Saido, T.; Karran, E.; Hyman, B.; Perry, V.H.; Fiers, M.; De Strooper, B. The major risk factors for alzheimer’s disease: Age, sex, and genes modulate the microglia response to Aβ plaques. Cell Rep., 2019, 27(4), 1293-1306.e6.
[http://dx.doi.org/10.1016/j.celrep.2019.03.099] [PMID: 31018141]

Grasso, G.; Giuffrida, M.L.; Rizzarelli, E. Metallostasis and amyloid β-degrading enzymes. Metallomics, 2012, 4(9), 937-949.
[http://dx.doi.org/10.1039/c2mt20105d] [PMID: 22832870]

Grasso, G.; Salomone, F.; Tundo, G.R.; Pappalardo, G.; Ciaccio, C.; Spoto, G.; Pietropaolo, A.; Coletta, M.; Rizzarelli, E. Metal ions affect insulin-degrading enzyme activity. J. Inorg. Biochem., 2012, 117, 351-358.
[http://dx.doi.org/10.1016/j.jinorgbio.2012.06.010] [PMID: 22819648]

Bush, A.I.; Tanzi, R.E. Therapeutics for Alzheimer’s disease based on the metal hypothesis. Neurotherapeutics, 2008, 5(3), 421-432.
[http://dx.doi.org/10.1016/j.nurt.2008.05.001] [PMID: 18625454]

Ross, C.A.; Poirier, M.A. Protein aggregation and neurodegenerative disease. Nat. Med., 2004, 10(S7)(Suppl.), S10-S17.
[http://dx.doi.org/10.1038/nm1066] [PMID: 15272267]

Wolfe, L.S.; Calabrese, M.F.; Nath, A.; Blaho, D.V.; Miranker, A.D.; Xiong, Y. Protein-induced photophysical changes to the amyloid indicator dye thioflavin T. Proc. Natl. Acad. Sci. USA, 2010, 107(39), 16863-16868.
[http://dx.doi.org/10.1073/pnas.1002867107] [PMID: 20826442]

Bartels, T.; Selkoe, D.J. Bartels & Selkoe reply. Nature, 2013, 498(7453), E6-E7.
[http://dx.doi.org/10.1038/nature12126]

De Simone, A.; Naldi, M.; Tedesco, D.; Milelli, A.; Bartolini, M.; Davani, L.; Widera, D.; Dallas, M.L.; Andrisano, V. Investigating in vitro amyloid peptide 1–42 aggregation: Impact of higher molecular weight stable adducts. ACS Omega, 2019, 4(7), 12308-12318.
[http://dx.doi.org/10.1021/acsomega.9b01531] [PMID: 31460348]

Hassan, R.; Abedin, F.; Tatulian, S.A. Interaction of Aβ1-42 and Aβ1-40 with lipid membranes studied by circular dichroism and fluorescence spectroscopy. Biophys. J., 2022, 121(3)(Suppl. 1), 226a.
[http://dx.doi.org/10.1016/j.bpj.2021.11.1612]

Kuret, J.; Chirita, C.N.; Congdon, E.E.; Kannanayakal, T.; Li, G.; Necula, M.; Yin, H.; Zhong, Q. Pathways of tau fibrillization. Biochim. Biophys. Acta Mol. Basis Dis., 2005, 1739(2-3), 167-178.
[http://dx.doi.org/10.1016/j.bbadis.2004.06.016] [PMID: 15615636]

Mensch, C.; Konijnenberg, A.; Van Elzen, R.; Lambeir, A.M.; Sobott, F.; Johannessen, C. Raman optical activity of human α -synuclein in intrinsically disordered, micelle-bound α -helical, molten globule and oligomeric β -sheet state. J. Raman Spectrosc., 2017, 48(7), 910-918.
[http://dx.doi.org/10.1002/jrs.5149]

Sinopoli, A.; Magrì, A.; Milardi, D.; Pappalardo, M.; Pucci, P.; Flagiello, A.; Titman, J.J.; Nicoletti, V.G.; Caruso, G.; Pappalardo, G.; Grasso, G. The role of copper( II ) in the aggregation of human amylin. Metallomics, 2014, 6(10), 1841-1852.
[http://dx.doi.org/10.1039/C4MT00130C] [PMID: 25080969]

Grasso, G.; Titman, J.J. Chain folding and diffusion in monodisperse long n -alkanes by solid-state NMR. Macromolecules, 2009, 42(12), 4175-4180.
[http://dx.doi.org/10.1021/ma801049j]

Leshem, G.; Richman, M.; Lisniansky, E.; Antman-Passig, M.; Habashi, M.; Gräslund, A.; Wärmländer, S.K.T.S.; Rahimipour, S. Photoactive chlorin e6 is a multifunctional modulator of amyloid-β aggregation and toxicity via specific interactions with its histidine residues. Chem. Sci. (Camb.), 2019, 10(1), 208-217.
[http://dx.doi.org/10.1039/C8SC01992D] [PMID: 30713632]

Sekhar, A.; Rumfeldt, J.A.O.; Broom, H.R.; Doyle, C.M.; Sobering, R.E.; Meiering, E.M.; Kay, L.E. Probing the free energy landscapes of ALS disease mutants of SOD1 by NMR spectroscopy. Proc. Natl. Acad. Sci. USA, 2016, 113(45), E6939-E6945.
[http://dx.doi.org/10.1073/pnas.1611418113] [PMID: 27791136]

Kotler, S.A.; Tugarinov, V.; Schmidt, T.; Ceccon, A.; Libich, D.S.; Ghirlando, R.; Schwieters, C.D.; Clore, G.M. Probing initial transient oligomerization events facilitating Huntingtin fibril nucleation at atomic resolution by relaxation-based NMR. Proc. Natl. Acad. Sci. USA, 2019, 116(9), 3562-3571.
[http://dx.doi.org/10.1073/pnas.1821216116] [PMID: 30808748]

Konermann, L.; Pan, J.; Liu, Y.H. Hydrogen exchange mass spectrometry for studying protein structure and dynamics. Chem. Soc. Rev., 2011, 40(3), 1224-1234.
[http://dx.doi.org/10.1039/C0CS00113A] [PMID: 21173980]

Heck, A.J.R. Native mass spectrometry: A bridge between interactomics and structural biology. Nat. Methods, 2008, 5(11), 927-933.
[http://dx.doi.org/10.1038/nmeth.1265] [PMID: 18974734]

Ruotolo, B.T.; Benesch, J.L.P.; Sandercock, A.M.; Hyung, S.J.; Robinson, C.V. Ion mobility–mass spectrometry analysis of large protein complexes. Nat. Protoc., 2008, 3(7), 1139-1152.
[http://dx.doi.org/10.1038/nprot.2008.78] [PMID: 18600219]

Ganguly, P.; Do, T.D.; Larini, L.; LaPointe, N.E.; Sercel, A.J.; Shade, M.F.; Feinstein, S.C.; Bowers, M.T.; Shea, J.E. Tau assembly: The dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3. J. Phys. Chem. B, 2015, 119(13), 4582-4593.
[http://dx.doi.org/10.1021/acs.jpcb.5b00175] [PMID: 25775228]

Lesné, S.; Koh, M.T.; Kotilinek, L.; Kayed, R.; Glabe, C.G.; Yang, A.; Gallagher, M.; Ashe, K.H. A specific amyloid-β protein assembly in the brain impairs memory. Nature, 2006, 440(7082), 352-357.
[http://dx.doi.org/10.1038/nature04533] [PMID: 16541076]

Illes-Toth, E.; Ramos, M.R.; Cappai, R.; Dalton, C.; Smith, D.P. Distinct higher-order α-synuclein oligomers induce intracellular aggregation. Biochem. J., 2015, 468(3), 485-493.
[http://dx.doi.org/10.1042/BJ20150159] [PMID: 25851527]

Arndt, J.R.; Kondalaji, S.G.; Maurer, M.M.; Parker, A.; Legleiter, J.; Valentine, S.J. Huntingtin N-terminal monomeric and multimeric structures destabilized by covalent modification of heteroatomic residues. Biochemistry, 2015, 54(28), 4285-4296.
[http://dx.doi.org/10.1021/acs.biochem.5b00478] [PMID: 26098795]

Murphy, C.J.; Gole, A.M.; Stone, J.W.; Sisco, P.N.; Alkilany, A.M.; Goldsmith, E.C.; Baxter, S.C. Gold nanoparticles in biology: Beyond toxicity to cellular imaging. Acc. Chem. Res., 2008, 41(12), 1721-1730.
[http://dx.doi.org/10.1021/ar800035u] [PMID: 18712884]

Siddique, S.; Chow, J.C.L. Gold nanoparticles for drug delivery and cancer therapy. Appl. Sci. (Basel), 2020, 10(11), 3824.
[http://dx.doi.org/10.3390/app10113824]

Baptista, P.; Fernandes, A.; Figueiredo, S.; Vinhas, R.; Cordeiro, M.; Carlos, F.; Mendo, S. Gold nanoparticle-based theranostics: Disease diagnostics and treatment using a single nanomaterial. Nanobiosens. dis. diagn., 2015, 4, 11-23.
[http://dx.doi.org/10.2147/NDD.S60285]

Chen, P.C.; Roy, P.; Chen, L.Y.; Ravindranath, R.; Chang, H.T. Gold and silver nanomaterial-based optical sensing systems. Part. Part. Syst. Charact., 2014, 31(9), 917-942.
[http://dx.doi.org/10.1002/ppsc.201400043]

Wood, R.W. XLII. On a remarkable case of uneven distribution of light in a diffraction grating spectrum. Lond. Edinb. Dublin Philos. Mag. J. Sci., 1902, 4(21), 396-402.
[http://dx.doi.org/10.1080/14786440209462857]

Ritchie, R.H. Plasma losses by fast electrons in thin films. Phys. Rev., 1957, 106(5), 874-881.
[http://dx.doi.org/10.1103/PhysRev.106.874]

Powell, C.J.; Swan, J.B. Effect of oxidation on the characteristic loss spectra of aluminum and magnesium. Phys. Rev., 1960, 118(3), 640-643.
[http://dx.doi.org/10.1103/PhysRev.118.640]

Liedberg, B.; Nylander, C.; Lunström, I. Surface plasmon resonance for gas detection and biosensing. Sens. Actuators, 1983, 4, 299-304.
[http://dx.doi.org/10.1016/0250-6874(83)85036-7]

Guo, X. Surface plasmon resonance based biosensor technique: A review. J. Biophotonics, 2012, 5(7), 483-501.
[http://dx.doi.org/10.1002/jbio.201200015] [PMID: 22467335]

Yesudasu, V.; Pradhan, H.S.; Pandya, R.J. Recent progress in surface plasmon resonance based sensors: A comprehensive review. Heliyon, 2021, 7(3), e06321.
[http://dx.doi.org/10.1016/j.heliyon.2021.e06321] [PMID: 33869818]

Sharma, A.K.; Jha, R.; Gupta, B.D. Fiber-optic sensors based on surface plasmon resonance: A comprehensive review. IEEE Sens. J., 2007, 7(8), 1118-1129.
[http://dx.doi.org/10.1109/JSEN.2007.897946]

Kurihara, K.; Suzuki, K. Theoretical understanding of an absorption-based surface plasmon resonance sensor based on Kretchmann’s theory. Anal. Chem., 2002, 74(3), 696-701.
[http://dx.doi.org/10.1021/ac010820+] [PMID: 11838698]

Neff, H.; Zong, W.; Lima, A.M.N.; Borre, M.; Holzhüter, G. Optical properties and instrumental performance of thin gold films near the surface plasmon resonance. Thin Solid Films, 2006, 496(2), 688-697.
[http://dx.doi.org/10.1016/j.tsf.2005.08.226]

Cardona, M. Fresnel reflection and surface plasmons. Am. J. Phys., 1971, 39(10), 1277-1277.
[http://dx.doi.org/10.1119/1.1976627]

Malmqvist, M. Biospecific interaction analysis using biosensor technology. Nature, 1993, 361(6408), 186-187.
[http://dx.doi.org/10.1038/361186a0] [PMID: 7678451]

Tumolo, T.; Angnes, L.; Baptista, M.S. Determination of the refractive index increment of molecule and macromolecule solutions by surface plasmon resonance. Anal. Biochem., 2004, 333(2), 273-279.
[http://dx.doi.org/10.1016/j.ab.2004.06.010] [PMID: 15450802]

Campbell, C.; Kim, G. SPR microscopy and its applications to high-throughput analyses of biomolecular binding events and their kinetics. Biomaterials, 2007, 28(15), 2380-2392.
[http://dx.doi.org/10.1016/j.biomaterials.2007.01.047] [PMID: 17337300]

Andersson, K.; Hämäläinen, M.; Malmqvist, M. Identification and optimization of regeneration conditions for affinity-based biosensor assays. A multivariate cocktail approach. Anal. Chem., 1999, 71(13), 2475-2481.
[http://dx.doi.org/10.1021/ac981271j] [PMID: 10405611]

Pratt, K.C.; Wakeham, W.A.; Ubbelohde, A.R.J.P. The mutual diffusion coefficient of ethanol–water mixtures: Determination by a rapid, new method. Proc. R. Soc. Lond. A Math. Phys. Sci., 1974, 336(1606), 393-406.
[http://dx.doi.org/10.1098/rspa.1974.0026]

Quinn, J.G. Evaluation of Taylor dispersion injections: Determining kinetic/affinity interaction constants and diffusion coefficients in label-free biosensing. Anal. Biochem., 2012, 421(2), 401-410.
[http://dx.doi.org/10.1016/j.ab.2011.11.023] [PMID: 22197422]

Quinn, J.G. Modeling Taylor dispersion injections: Determination of kinetic/affinity interaction constants and diffusion coefficients in label-free biosensing. Anal. Biochem., 2012, 421(2), 391-400.
[http://dx.doi.org/10.1016/j.ab.2011.11.024] [PMID: 22197421]

Loureiro, F.C.C.L.; Barreto Neto, A.G.S.; Moreira, C.S.; Lima, A.M.N.; Neff, H. A method for determining the mutual diffusion coefficient of molecular solutes based on surface plasmon resonance sensing. Sens. Actuators B Chem., 2011, 154(2), 129-136.
[http://dx.doi.org/10.1016/j.snb.2010.02.023]

Iwasaki, Y.; Seyama, M.; Matsuura, N.; Inoue, S.; Hayashi, K.; Koizumi, H. Direct measurement of near-wall molecular transport rate in a microchannel and its dependence on diffusivity. Langmuir, 2021, 37(29), 8687-8695.
[http://dx.doi.org/10.1021/acs.langmuir.1c00561] [PMID: 34270898]

G.A. Zingale, I. Pandino, A. Distefano, N. Tuccitto, G. Grasso. A novel SPR based method for measuring diffusion coefficients: From small molecules to supramolecular aggregates. Biosensors & Bioelectronics: X (2023) 13, 100306.

Distefano, A.; Caruso, G.; Oliveri, V.; Bellia, F.; Sbardella, D.; Zingale, G.A.; Caraci, F.; Grasso, G. Neuroprotective effect of carnosine is mediated by insulin-degrading enzyme. ACS Chem. Neurosci., 2022, 13(10), 1588-1593.
[http://dx.doi.org/10.1021/acschemneuro.2c00201] [PMID: 35471926]

Wittenberg, N.J.; Wootla, B.; Jordan, L.R.; Denic, A.; Warrington, A.E.; Oh, S-H.; Rodriguez, M. Applications of surface plasmon resonance for characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseases. Expert Rev. Neurother., 2014, 14(4), 449-463.
[http://dx.doi.org/10.1586/14737175.2014.896199] [PMID: 24625008]

Ciaccio, C.; Tundo, G.R.; Grasso, G.; Spoto, G.; Marasco, D.; Ruvo, M.; Gioia, M.; Rizzarelli, E.; Coletta, M. Somatostatin: A novel substrate and a modulator of insulin-degrading enzyme activity. J. Mol. Biol., 2009, 385(5), 1556-1567.
[http://dx.doi.org/10.1016/j.jmb.2008.11.025] [PMID: 19073193]

Grasso, G.; D’Agata, R.; Zanoli, L.; Spoto, G. Microfluidic networks for surface plasmon resonance imaging real-time kinetics experiments. Microchem. J., 2009, 93(1), 82-86.
[http://dx.doi.org/10.1016/j.microc.2009.05.001]

Mariani, S.; Minunni, M. Surface plasmon resonance applications in clinical analysis. Anal. Bioanal. Chem., 2014, 406(9-10), 2303-2323.
[http://dx.doi.org/10.1007/s00216-014-7647-5] [PMID: 24566759]

Sota, H.; Hasegawa, Y.; Iwakura, M. Detection of conformational changes in an immobilized protein using surface plasmon resonance. Anal. Chem., 1998, 70(10), 2019-2024.
[http://dx.doi.org/10.1021/ac9713666] [PMID: 9608841]

Dell’Orco, D.; Koch, K.W. Fingerprints of calcium-binding protein conformational dynamics monitored by surface plasmon resonance. ACS Chem. Biol., 2016, 11(9), 2390-2397.
[http://dx.doi.org/10.1021/acschembio.6b00470] [PMID: 27380526]

Dell’Orco, D.; Müller, M.; Koch, K.W. Quantitative detection of conformational transitions in a calcium sensor protein by surface plasmon resonance. Chem. Commun. (Camb.), 2010, 46(39), 7316-7318.
[http://dx.doi.org/10.1039/c0cc02086a] [PMID: 20835460]

Riedel, T.; Majek, P.; Rodriguez-Emmenegger, C.; Brynda, E. Surface plasmon resonance: Advances of label-free approaches in the analysis of biological samples. Bioanalysis, 2014, 6(24), 3325-3336.
[http://dx.doi.org/10.4155/bio.14.246] [PMID: 25534789]

Paynter, S.; Russell, D.A. Surface plasmon resonance measurement of pH-induced responses of immobilized biomolecules: Conformational change or electrostatic interaction effects? Anal. Biochem., 2002, 309(1), 85-95.
[http://dx.doi.org/10.1016/S0003-2697(02)00255-5] [PMID: 12381366]

Grasso, G.; Satriano, C.; Milardi, D. A neglected modulator of insulin-degrading enzyme activity and conformation: The pH. Biophys. Chem., 2015, 203-204, 33-40.
[http://dx.doi.org/10.1016/j.bpc.2015.05.010] [PMID: 26025789]

Yao, F.; He, J.; Li, X.; Zou, H.; Yuan, Z. Studies of interaction of copper and zinc ions with Alzheimer’s Aβ(1–16) using surface plasmon resonance spectrometer. Sens. Actuators B Chem., 2012, 161(1), 886-891.
[http://dx.doi.org/10.1016/j.snb.2011.11.057]

Grasso, G.; Pietropaolo, A.; Spoto, G.; Pappalardo, G.; Tundo, G.R.; Ciaccio, C.; Coletta, M.; Rizzarelli, E. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: Implications for metallostasis alteration in Alzheimer’s disease. Chemistry, 2011, 17(9), 2752-2762.
[http://dx.doi.org/10.1002/chem.201002809] [PMID: 21274957]

Grasso, G.; Spoto, G. Plasmonics for the study of metal ion–protein interactions. Anal. Bioanal. Chem., 2013, 405(6), 1833-1843.
[http://dx.doi.org/10.1007/s00216-012-6421-9] [PMID: 23052866]

Gestwicki, J.E.; Hsieh, H.V.; Pitner, J.B. Using receptor conformational change to detect low molecular weight analytes by surface plasmon resonance. Anal. Chem., 2001, 73(23), 5732-5737.
[http://dx.doi.org/10.1021/ac0105888] [PMID: 11774914]

Grasso, G. Ubiquitin binds the amyloid /beta peptide and interferes with its clearance pathways. Chem. Sci., 2019, 10(9), 2732-2742.
[http://dx.doi.org/10.1039/C8SC03394C]

Grasso, G.; Rizzarelli, E.; Spoto, G. How the binding and degrading capabilities of insulin degrading enzyme are affected by ubiquitin. Biochim. Biophys. Acta. Proteins Proteomics, 2008, 1784(7-8), 1122-1126.
[http://dx.doi.org/10.1016/j.bbapap.2008.04.011] [PMID: 18489915]

Gioia, M.; Monaco, S.; Van Den Steen, P.E.; Sbardella, D.; Grasso, G.; Marini, S.; Overall, C.M.; Opdenakker, G.; Coletta, M. The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B. J. Mol. Biol., 2009, 386(2), 419-434.
[http://dx.doi.org/10.1016/j.jmb.2008.12.021] [PMID: 19109975]

Lund-Katz, S.; Nguyen, D.; Dhanasekaran, P.; Kono, M.; Nickel, M.; Saito, H.; Phillips, M.C. Surface plasmon resonance analysis of the mechanism of binding of apoA-I to high density lipoprotein particles. J. Lipid Res., 2010, 51(3), 606-617.
[http://dx.doi.org/10.1194/jlr.M002055] [PMID: 19786567]

Yamaguchi, S.; Mannen, T.; Zako, T.; Kamiya, N.; Nagamune, T. Measuring adsorption of a hydrophobic probe with a surface plasmon resonance sensor to monitor conformational changes in immobilized proteins. Biotechnol. Prog., 2003, 19(4), 1348-1354.
[http://dx.doi.org/10.1021/bp034015n] [PMID: 12892501]

Grasso, G.; Bush, A.I.; D’Agata, R.; Rizzarelli, E.; Spoto, G. Enzyme solid-state support assays: A surface plasmon resonance and mass spectrometry coupled study of immobilized insulin degrading enzyme. Eur. Biophys. J., 2009, 38(4), 407-414.
[http://dx.doi.org/10.1007/s00249-008-0384-y] [PMID: 19048247]

Myszka, D.G.; Wood, S.J.; Biere, A.L. Analysis of fibril elongation using surface plasmon resonance biosensors. Methods Enzymol., 1999, 309, 386-402.
[http://dx.doi.org/10.1016/S0076-6879(99)09027-8] [PMID: 10507037]

Distefano, A.; Antonio Zingale, G.; Grasso, G. An SPR-based method for Hill coefficient measurements: The case of insulin-degrading enzyme. Anal. Bioanal. Chem., 2022, 414(17), 4793-4802.
[http://dx.doi.org/10.1007/s00216-022-04122-3] [PMID: 35577931]

Robinson, P.K. Enzymes: Principles and biotechnological applications. Essays Biochem., 2015, 59, 1-41.
[http://dx.doi.org/10.1042/bse0590001] [PMID: 26504249]

Majka, J.; Speck, C. Analysis of protein-DNA interactions using surface plasmon resonance. Adv. Biochem. Eng. Biotechnol., 2007, 104, 13-36.
[http://dx.doi.org/10.1007/10_026] [PMID: 17290817]

Lang Hrtska, S.C.; Kemp, M.M.; Muñoz, E.M.; Azizad, O.; Banerjee, M.; Raposo, C.; Kumaran, J.; Ghosh, P.; Linhardt, R.J. Investigation of the mechanism of binding between internalin B and heparin using surface plasmon resonance. Biochemistry, 2007, 46(10), 2697-2706.
[http://dx.doi.org/10.1021/bi062021x] [PMID: 17305366]

Della Pia, E.A.; Martinez, K.L. Single domain antibodies as a powerful tool for high quality surface plasmon resonance studies. PLoS One, 2015, 10(3), e0124303.
[http://dx.doi.org/10.1371/journal.pone.0124303] [PMID: 25822527]

Sarcina, L.; Mangiatordi, G.F.; Torricelli, F.; Bollella, P.; Gounani, Z.; Österbacka, R.; Macchia, E.; Torsi, L. Surface Plasmon Resonance Assay for Label-Free and Selective Detection of HIV-1 p24 Protein. Biosensors (Basel), 2021, 11(6), 180.
[http://dx.doi.org/10.3390/bios11060180] [PMID: 34204930]

Ramakrishnan, M.; Kandimalla, K.K.; Wengenack, T.M.; Howell, K.G.; Poduslo, J.F. Surface plasmon resonance binding kinetics of Alzheimer’s disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies. Biochemistry, 2009, 48(43), 10405-10415.
[http://dx.doi.org/10.1021/bi900523q] [PMID: 19775170]

Aguilar, M.I.; Small, D.H. Surface plasmon resonance for the analysis of β-amyloid interactions and fibril formation in Alzheimer’s disease research. Neurotox. Res., 2005, 7(1-2), 17-27.
[http://dx.doi.org/10.1007/BF03033773] [PMID: 15639795]

Kraziński, B.E.; Radecki, J.; Radecka, H. Surface plasmon resonance based biosensors for exploring the influence of alkaloids on aggregation of amyloid-β peptide. Sensors (Basel), 2011, 11(4), 4030-4042.
[http://dx.doi.org/10.3390/s110404030] [PMID: 22163834]

Cheng, X.R.; Hau, B.Y.H.; Veloso, A.J.; Martic, S.; Kraatz, H.B.; Kerman, K. Surface plasmon resonance imaging of amyloid-β aggregation kinetics in the presence of epigallocatechin gallate and metals. Anal. Chem., 2013, 85(4), 2049-2055.
[http://dx.doi.org/10.1021/ac303181q] [PMID: 23276205]

Kobayashi, S.; Tanaka, Y.; Kiyono, M.; Chino, M.; Chikuma, T.; Hoshi, K.; Ikeshima, H. Dependence pH and proposed mechanism for aggregation of Alzheimer’s disease-related amyloid-β(1–42) protein. J. Mol. Struct., 2015, 1094, 109-117.
[http://dx.doi.org/10.1016/j.molstruc.2015.03.023]

Hortschansky, P.; Schroeckh, V.; Christopeit, T.; Zandomeneghi, G.; Fändrich, M. The aggregation kinetics of Alzheimer’s β-amyloid peptide is controlled by stochastic nucleation. Protein Sci., 2005, 14(7), 1753-1759.
[http://dx.doi.org/10.1110/ps.041266605] [PMID: 15937275]

Xue, C.; Lin, T.Y.; Chang, D.; Guo, Z. Thioflavin T as an amyloid dye: Fibril quantification, optimal concentration and effect on aggregation. R. Soc. Open Sci., 2017, 4(1), 160696.
[http://dx.doi.org/10.1098/rsos.160696] [PMID: 28280572]

Groenning, M. Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status. J. Chem. Biol., 2010, 3(1), 1-18.
[http://dx.doi.org/10.1007/s12154-009-0027-5] [PMID: 19693614]

Forloni, G.; Balducci, C. Alzheimer’s disease, oligomers, and inflammation. J. Alzheimers Dis., 2018, 62(3), 1261-1276.
[http://dx.doi.org/10.3233/JAD-170819] [PMID: 29562537]

Jameson, L.P.; Smith, N.W.; Dzyuba, S.V. Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly. ACS Chem. Neurosci., 2012, 3(11), 807-819.
[http://dx.doi.org/10.1021/cn300076x] [PMID: 23173064]

Grasso, G. The use of mass spectrometry to study amyloid-β peptides. Mass Spectrom. Rev., 2011, 30(3), 347-365.
[http://dx.doi.org/10.1002/mas.20281] [PMID: 21500241]

Grasso, G. Mass spectrometry is a multifaceted weapon to be used in the battle against Alzheimer’s disease: Amyloid beta peptides and beyond. Mass Spectrom. Rev., 2019, 38(1), 34-48.
[http://dx.doi.org/10.1002/mas.21566]

Grasso, G. Theuse of mass spectrometry to study zn-metalloprotease-substrate interactions. Mass Spectrom. Rev., 2020, 39(5-6), 574-585.
[http://dx.doi.org/10.1002/mas.21621] [PMID: 31898821]

Ryu, J.; Joung, H.A.; Kim, M.G.; Park, C.B. Surface plasmon resonance analysis of Alzheimer’s β-amyloid aggregation on a solid surface: From monomers to fully-grown fibrils. Anal. Chem., 2008, 80(7), 2400-2407.
[http://dx.doi.org/10.1021/ac7019514] [PMID: 18303863]

Palladino, P.; Aura, A.M.; Spoto, G. Surface plasmon resonance for the label-free detection of Alzheimer’s β-amyloid peptide aggregation. Anal. Bioanal. Chem., 2016, 408(3), 849-854.
[http://dx.doi.org/10.1007/s00216-015-9172-6] [PMID: 26558762]

Lee, J.; Lee, K.; Lim, C.T. Surface plasmon resonance assay for identification of small molecules capable of inhibiting Aβ aggregation. ACS Appl. Mater. Interfaces, 2021, 13(24), 27845-27855.
[http://dx.doi.org/10.1021/acsami.1c04833] [PMID: 34110774]

Liu, L.; Xia, N.; Wang, J. Potential applications of SPR in early diagnosis and progression of Alzheimer’s disease. RSC Advances, 2012, 2(6), 2200-2204.
[http://dx.doi.org/10.1039/c2ra00667g]

Špringer, T.; Hemmerová, E.; Finocchiaro, G.; Krištofiková, Z.; Vyhnálek, M.; Homola, J. Surface plasmon resonance biosensor for the detection of tau -amyloid β complex. Sens. Actuat. B Chem., 2020, 316, 128146.
[http://dx.doi.org/10.1016/j.snb.2020.128146]

Rezabakhsh, A.; Rahbarghazi, R.; Fathi, F. Surface plasmon resonance biosensors for detection of Alzheimer’s biomarkers; an effective step in early and accurate diagnosis. Biosens. Bioelectron., 2020, 167, 112511.
[http://dx.doi.org/10.1016/j.bios.2020.112511] [PMID: 32858422]

Chan, H.N.; Xu, D.; Ho, S.L.; Wong, M.S.; Li, H.W. Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer’s disease. Chem. Sci. (Camb.), 2017, 8(5), 4012-4018.
[http://dx.doi.org/10.1039/C6SC05615F] [PMID: 30155210]

Karki, H.P.; Jang, Y.; Jung, J.; Oh, J. Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease. J. Nanobiotechnology, 2021, 19(1), 72.
[http://dx.doi.org/10.1186/s12951-021-00814-7] [PMID: 33750392]

Anoop, A.; Singh, P.K.; Jacob, R.S.; Maji, S.K. CSF biomarkers for Alzheimer’s disease diagnosis. Int. J. Alzheimers Dis., 2010, 2010, 606802.
[http://dx.doi.org/10.4061/2010/606802] [PMID: 20721349]

Blennow, K.; Zetterberg, H. Biomarkers for Alzheimer’s disease: Current status and prospects for the future. J. Intern. Med., 2018, 284(6), 643-663.
[http://dx.doi.org/10.1111/joim.12816] [PMID: 30051512]

Xia, N.; Liu, L.; Harrington, M.G.; Wang, J.; Zhou, F. Regenerable and simultaneous surface plasmon resonance detection of aβ(1-40) and aβ(1-42) peptides in cerebrospinal fluids with signal amplification by streptavidin conjugated to an N-terminus-specific antibody. Anal. Chem., 2010, 82(24), 10151-10157.
[http://dx.doi.org/10.1021/ac102257m] [PMID: 21073166]

Sengupta, U.; Nilson, A.N.; Kayed, R. The role of amyloid-β oligomers in toxicity, propagation, and immunotherapy. EBioMedicine, 2016, 6, 42-49.
[http://dx.doi.org/10.1016/j.ebiom.2016.03.035] [PMID: 27211547]

Stravalaci, M.; Bastone, A.; Beeg, M.; Cagnotto, A.; Colombo, L.; Di Fede, G.; Tagliavini, F.; Cantù, L.; Del Favero, E.; Mazzanti, M.; Chiesa, R.; Salmona, M.; Diomede, L.; Gobbi, M. Specific recognition of biologically active amyloid-β oligomers by a new surface plasmon resonance-based immunoassay and an in vivo assay in caenorhabditis elegans. J. Biol. Chem., 2012, 287(33), 27796-27805.
[http://dx.doi.org/10.1074/jbc.M111.334979] [PMID: 22736768]

Yi, X.; Feng, C.; Hu, S.; Li, H.; Wang, J. Surface plasmon resonance biosensors for simultaneous monitoring of amyloid-beta oligomers and fibrils and screening of select modulators. Analyst (Lond.), 2016, 141(1), 331-336.
[http://dx.doi.org/10.1039/C5AN01864A] [PMID: 26613550]

Dehghani, M.; Jalal, R.; Rashidi, M.R. Kinetic and thermodynamic insights into the interaction of Aβ1–42 with astaxanthin and aggregation behavior of Aβ1–42: Surface plasmon resonance, microscopic, and molecular docking studies. Biophys. Chem., 2021, 275, 106612.
[http://dx.doi.org/10.1016/j.bpc.2021.106612] [PMID: 33984664]

Arndt, J.W.; Qian, F.; Smith, B.A.; Quan, C.; Kilambi, K.P.; Bush, M.W.; Walz, T.; Pepinsky, R.B.; Bussière, T.; Hamann, S.; Cameron, T.O.; Weinreb, P.H. Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β. Sci. Rep., 2018, 8(1), 6412.
[http://dx.doi.org/10.1038/s41598-018-24501-0] [PMID: 29686315]

Parnetti, L.; Gaetani, L.; Eusebi, P.; Paciotti, S.; Hansson, O.; El-Agnaf, O.; Mollenhauer, B.; Blennow, K.; Calabresi, P. CSF and blood biomarkers for Parkinson’s disease. Lancet Neurol., 2019, 18(6), 573-586.
[http://dx.doi.org/10.1016/S1474-4422(19)30024-9] [PMID: 30981640]

Ganguly, U.; Singh, S.; Pal, S.; Prasad, S.; Agrawal, B.K.; Saini, R.V.; Chakrabarti, S. Alpha-synuclein as a biomarker of parkinson’s disease: Good, but not good enough. Front. Aging Neurosci., 2021, 13, 702639.
[http://dx.doi.org/10.3389/fnagi.2021.702639] [PMID: 34305577]

Gao, H.; Zhao, Z.; He, Z.; Wang, H.; Liu, M.; Hu, Z.; Cheng, O.; Yang, Y.; Zhu, L. Detection of Parkinson’s disease through the peptoid recognizing α-synuclein in serum. ACS Chem. Neurosci., 2019, 10(3), 1204-1208.
[http://dx.doi.org/10.1021/acschemneuro.8b00540] [PMID: 30682886]

Zuckermann, R.N. Peptoid origins. Biopolymers, 2011, 96(5), 545-555.
[http://dx.doi.org/10.1002/bip.21573] [PMID: 21184486]

Mandala, S.H.S.; Liu, T.J.; Chen, C.M.; Liu, K.K.; Januar, M.; Chang, Y.F.; Lai, C.S.; Chang, K.H.; Liu, K.C. Enhanced plasmonic biosensor utilizing paired antibody and label-free Fe₃O₄ nanoparticles for highly sensitive and selective detection of Parkinson’s α-synuclein in serum. Biosensors (Basel), 2021, 11(10), 402.
[http://dx.doi.org/10.3390/bios11100402] [PMID: 34677358]

Singh, A.P.; Ramana, G.; Bajaj, T.; Singh, V.; Dwivedi, S.; Behari, M.; Dey, A.B.; Dey, S. Elevated serum SIRT 2 may differentiate Parkinson’s disease from atypical parkinsonian syndromes. Front. Mol. Neurosci., 2019, 12, 129.
[http://dx.doi.org/10.3389/fnmol.2019.00129] [PMID: 31244600]

Chen, X.; Wales, P.; Quinti, L.; Zuo, F.; Moniot, S.; Herisson, F.; Rauf, N.A.; Wang, H.; Silverman, R.B.; Ayata, C.; Maxwell, M.M.; Steegborn, C.; Schwarzschild, M.A.; Outeiro, T.F.; Kazantsev, A.G. The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson’s disease but not amyotrophic lateral sclerosis and cerebral ischemia. PLoS One, 2015, 10(1), e0116919.
[http://dx.doi.org/10.1371/journal.pone.0116919] [PMID: 25608039]

Zoey, F.L.; Palanivel, M.; Padmanabhan, P.; Gulyás, B. Parkinson’s disease: A nanotheranostic approach targeting alpha-synuclein aggregation. Front. Cell Dev. Biol., 2021, 9, 707441.
[http://dx.doi.org/10.3389/fcell.2021.707441] [PMID: 34490255]

Sun, K.; Xia, N.; Zhao, L.; Liu, K.; Hou, W.; Liu, L. Aptasensors for the selective detection of alpha-synuclein oligomer by colorimetry, surface plasmon resonance and electrochemical impedance spectroscopy. Sens. Actuators B Chem., 2017, 245, 87-94.
[http://dx.doi.org/10.1016/j.snb.2017.01.171]

Kumar, J.; Eraña, H.; López-Martínez, E.; Claes, N.; Martín, V.F.; Solís, D.M.; Bals, S.; Cortajarena, A.L.; Castilla, J.; Liz-Marzán, L.M. Detection of amyloid fibrils in Parkinson’s disease using plasmonic chirality. Proc. Natl. Acad. Sci. USA, 2018, 115(13), 3225-3230.
[http://dx.doi.org/10.1073/pnas.1721690115] [PMID: 29531058]

Fink, A.L. The aggregation and fibrillation of α-synuclein. Acc. Chem. Res., 2006, 39(9), 628-634.
[http://dx.doi.org/10.1021/ar050073t] [PMID: 16981679]

Dubackic, M.; Linse, S.; Sparr, E.; Olsson, U. Comparing α-synuclein fibrils formed in the absence and presence of a model lipid membrane: A small and wide-angle X-ray scattering study. Front. Soft Matter., 2022, 1, 741996.
[http://dx.doi.org/10.3389/frsfm.2021.741996]

Honarmand, S.; Dabirmanesh, B.; Amanlou, M.; Khajeh, K. The interaction of several herbal extracts with α-synuclein: Fibril formation and surface plasmon resonance analysis. PLoS One, 2019, 14(6), e0217801.
[http://dx.doi.org/10.1371/journal.pone.0217801] [PMID: 31185031]

Tóth, G.; Neumann, T.; Berthet, A.; Masliah, E.; Spencer, B.; Tao, J.; Jobling, M.F.; Gardai, S.J.; Bertoncini, C.W.; Cremades, N.; Bova, M.; Ballaron, S.; Chen, X.H.; Mao, W.; Nguyen, P.; Tabios, M.C.; Tambe, M.A.; Rochet, J.C.; Junker, H.D.; Schwizer, D.; Sekul, R.; Ott, I.; Anderson, J.P.; Szoke, B.; Hoffman, W.; Christodoulou, J.; Yednock, T.; Agard, D.A.; Schenk, D.; McConlogue, L. Novel small molecules targeting the intrinsically disordered structural ensemble of α-synuclein protect against diverse α-synuclein mediated dysfunctions. Sci. Rep., 2019, 9(1), 16947.
[http://dx.doi.org/10.1038/s41598-019-52598-4] [PMID: 31740740]

Zhang, S.; Liu, Y.Q.; Jia, C.; Lim, Y.J.; Feng, G.; Xu, E.; Long, H.; Kimura, Y.; Tao, Y.; Zhao, C.; Wang, C.; Liu, Z.; Hu, J.J.; Ma, M.R.; Liu, Z.; Jiang, L.; Li, D.; Wang, R.; Dawson, V.L.; Dawson, T.M.; Li, Y.M.; Mao, X.; Liu, C. Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson’s disease. Proc. Natl. Acad. Sci. USA, 2021, 118(26), e2011196118.
[http://dx.doi.org/10.1073/pnas.2011196118] [PMID: 34172566]

Copeland, R.A.; Pompliano, D.L.; Meek, T.D. Drug–target residence time and its implications for lead optimization. Nat. Rev. Drug Discov., 2006, 5(9), 730-739.
[http://dx.doi.org/10.1038/nrd2082] [PMID: 16888652]

Leclerc, E.; Peretz, D.; Ball, H.; Sakurai, H.; Legname, G.; Serban, A.; Prusiner, S.B.; Burton, D.R.; Williamson, R.A. Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form. EMBO J., 2001, 20(7), 1547-1554.
[http://dx.doi.org/10.1093/emboj/20.7.1547] [PMID: 11285219]

Leclerc, E.; Vetter, S. Conformational changes and development of proteinase K resistance in surface-immobilized PrP. Arch. Virol., 2008, 153(4), 683-691.
[http://dx.doi.org/10.1007/s00705-008-0049-2] [PMID: 18278426]

Kim, S.Y.; Zhang, F.; Harris, D.A.; Linhardt, R.J. Structuralfeatures of heparin and its interactions with cellular prion protein measured by surface plasmon resonance. Front. Mol. Biosci., 2020, 7, 594497.
[http://dx.doi.org/10.3389/fmolb.2020.594497] [PMID: 33324681]

Lu, H.; Dong Le, W.; Xie, Y.Y.; Wang, X.P. Current therapy of drugs in amyotrophic lateral sclerosis. Curr. Neuropharmacol., 2016, 14(4), 314-321.
[http://dx.doi.org/10.2174/1570159X14666160120152423] [PMID: 26786249]

Xu, X.; Denic, A.; Jordan, L.R.; Wittenberg, N.J.; Warrington, A.E.; Wootla, B.; Papke, L.M.; Zoecklein, L.J.; Yoo, D.; Shaver, J.; Oh, S.H.; Pease, L.R.; Rodriguez, M. A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis. Dis. Model. Mech., 2015, 8(8), dmm.020727.
[http://dx.doi.org/10.1242/dmm.020727] [PMID: 26035393]

Shvil, N.; Banerjee, V.; Zoltsman, G.; Shani, T.; Kahn, J.; Abu-Hamad, S.; Papo, N.; Engel, S.; Bernhagen, J.; Israelson, A. MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: Implications for familial ALS. Cell Death Dis., 2018, 9(2), 107.
[http://dx.doi.org/10.1038/s41419-017-0130-4] [PMID: 29371591]

Hong, S.; Lee, S.; Choi, I.; Yang, Y.I.; Kang, T.; Yi, J. Real-time analysis and direct observations of different superoxide dismutase (SOD1) molecules bindings to aggregates in temporal evolution step. Colloids Surf. B Biointerfaces, 2013, 101, 266-271.
[http://dx.doi.org/10.1016/j.colsurfb.2012.06.014] [PMID: 23010029]

Kang, T.; Hong, S.; Choi, I.; Sung, J.J.; Kim, Y.; Hahn, J.S.; Yi, J. Reversible pH-driven conformational switching of tethered superoxide dismutase with gold nanoparticle enhanced surface plasmon resonance spectroscopy. J. Am. Chem. Soc., 2006, 128(39), 12870-12878.
[http://dx.doi.org/10.1021/ja0632198] [PMID: 17002381]

Bar-Tana, J. Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm. Rev. Endocr. Metab. Disord., 2020, 21(4), 613-629.
[http://dx.doi.org/10.1007/s11154-020-09545-w] [PMID: 32128655]

Bellia, F.; Grasso, G. The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme. J. Mass Spectrom., 2014, 49(4), 274-279.
[http://dx.doi.org/10.1002/jms.3338] [PMID: 24719342]

Hay, D.L.; Chen, S.; Lutz, T.A.; Parkes, D.G.; Roth, J.D. Amylin: Pharmacology, physiology, and clinical potential. Pharmacol. Rev., 2015, 67(3), 564-600.
[http://dx.doi.org/10.1124/pr.115.010629] [PMID: 26071095]

Pillay, K.; Govender, P. Novel insights into amylin aggregation. Biotechnol. Biotechnol. Equip., 2014, 28(1), 123-135.
[http://dx.doi.org/10.1080/13102818.2014.901680] [PMID: 26019498]

Xu, Y.; Maya-Martinez, R.; Guthertz, N.; Heath, G.R.; Manfield, I.W.; Breeze, A.L.; Sobott, F.; Foster, R.; Radford, S.E. Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly. Nat. Commun., 2022, 13(1), 1040.
[http://dx.doi.org/10.1038/s41467-022-28660-7] [PMID: 35210421]

Schneider, C.S.; Bhargav, A.G.; Perez, J.G.; Wadajkar, A.S.; Winkles, J.A.; Woodworth, G.F.; Kim, A.J. Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics. J. Control. Release, 2015, 219, 331-344.
[http://dx.doi.org/10.1016/j.jconrel.2015.09.048] [PMID: 26415854]

Banerjee, I.; Pangule, R.C.; Kane, R.S. Antifouling coatings: Recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms. Adv. Mater., 2011, 23(6), 690-718.
[http://dx.doi.org/10.1002/adma.201001215] [PMID: 20886559]

Blaszykowski, C.; Sheikh, S.; Thompson, M. Surface chemistry to minimize fouling from blood-based fluids. Chem. Soc. Rev., 2012, 41(17), 5599-5612.
[http://dx.doi.org/10.1039/c2cs35170f] [PMID: 22772072]

Mauriz, E.; Dey, P.; Lechuga, L.M. Advances in nanoplasmonic biosensors for clinical applications. Analyst (Lond.), 2019, 144(24), 7105-7129.
[http://dx.doi.org/10.1039/C9AN00701F] [PMID: 31663527]

Unsworth, L.D.; Tun, Z.; Sheardown, H.; Brash, J.L. Chemisorption of thiolated poly(ethylene oxide) to gold: Surface chain densities measured by ellipsometry and neutron reflectometry. J. Colloid Interface Sci., 2005, 281(1), 112-121.
[http://dx.doi.org/10.1016/j.jcis.2004.08.022] [PMID: 15567386]

Vaisocherová, H.; Brynda, E.; Homola, J. Functionalizable low-fouling coatings for label-free biosensing in complex biological media: Advances and applications. Anal. Bioanal. Chem., 2015, 407(14), 3927-3953.
[http://dx.doi.org/10.1007/s00216-015-8606-5] [PMID: 25821150]

Ederth, T.; Lerm, M.; Orihuela, B.; Rittschof, D. Resistance of zwitterionic peptide monolayers to biofouling. Langmuir, 2019, 35(5), 1818-1827.
[http://dx.doi.org/10.1021/acs.langmuir.8b01625] [PMID: 30103609]

Harris, J.M. Poly(Ethylene Glycol) Chemistry. Topics in Applied Chemistry (TAPP), (1^st ed.. ), 1992,
[http://dx.doi.org/10.1007/978-1-4899-0703-5]

Blackman, L.D.; Gunatillake, P.A.; Cass, P.; Locock, K.E.S. An introduction to zwitterionic polymer behavior and applications in solution and at surfaces. Chem. Soc. Rev., 2019, 48(3), 757-770.
[http://dx.doi.org/10.1039/C8CS00508G] [PMID: 30548039]

Liu, X.; Huang, R.; Su, R.; Qi, W.; Wang, L.; He, Z. Grafting hyaluronic acid onto gold surface to achieve low protein fouling in surface plasmon resonance biosensors. ACS Appl. Mater. Interfaces, 2014, 6(15), 13034-13042.
[http://dx.doi.org/10.1021/am502921z] [PMID: 25026640]

Jia, J.; Coyle, R.C.; Richards, D.J.; Berry, C.L.; Barrs, R.W.; Biggs, J.; James Chou, C.; Trusk, T.C.; Mei, Y. Development of peptide-functionalized synthetic hydrogel microarrays for stem cell and tissue engineering applications. Acta Biomater., 2016, 45, 110-120.
[http://dx.doi.org/10.1016/j.actbio.2016.09.006] [PMID: 27612960]

Prime, K.L.; Whitesides, G.M. Adsorption of proteins onto surfaces containing end-attached oligo(ethylene oxide): A model system using self-assembled monolayers. J. Am. Chem. Soc., 1993, 115(23), 10714-10721.
[http://dx.doi.org/10.1021/ja00076a032]

Liu, B.; Liu, X.; Shi, S.; Huang, R.; Su, R.; Qi, W.; He, Z. Design and mechanisms of antifouling materials for surface plasmon resonance sensors. Acta Biomater., 2016, 40, 100-118.
[http://dx.doi.org/10.1016/j.actbio.2016.02.035] [PMID: 26921775]

Qu, J.H.; Dillen, A.; Saeys, W.; Lammertyn, J.; Spasic, D. Advancements in SPR biosensing technology: An overview of recent trends in smart layers design, multiplexing concepts, continuous monitoring and in vivo sensing. Anal. Chim. Acta, 2020, 1104, 10-27.
[http://dx.doi.org/10.1016/j.aca.2019.12.067] [PMID: 32106939]

D’Agata, R.; Bellassai, N.; Giuffrida, M.C.; Aura, A.M.; Petri, C.; Kögler, P.; Vecchio, G.; Jonas, U.; Spoto, G. A new ultralow fouling surface for the analysis of human plasma samples with surface plasmon resonance. Talanta, 2021, 221, 121483.
[http://dx.doi.org/10.1016/j.talanta.2020.121483] [PMID: 33076094]

Schasfoort, R.B.M. Introduction to Surface Plasmon Resonance. In: Handbook of Surface Plasmon Resonance, 2^nd ed.; Royal Society of Chemistry: London: UK, 2010; 87, pp. (7)742-746.
[http://dx.doi.org/10.1039/9781788010283-00001]

Tang, Y.; Zeng, X.; Liang, J. Surface plasmon resonance: An introduction to a surface spectroscopy technique. J. Chem. Educ., 2010, 87(7), 742-746.
[http://dx.doi.org/10.1021/ed100186y] [PMID: 21359107]

Mohammadzadeh-Asl, S.; Keshtkar, A.; Ezzati Nazhad Dolatabadi, J.; de la Guardia, M. Nanomaterials and phase sensitive based signal enhancment in surface plasmon resonance. Biosens. Bioelectron., 2018, 110, 118-131.
[http://dx.doi.org/10.1016/j.bios.2018.03.051] [PMID: 29604520]

Chang, C.C. Recent advancements in aptamer-based surface plasmon resonance biosensing strategies. Biosensors (Basel), 2021, 11(7), 233.
[http://dx.doi.org/10.3390/bios11070233] [PMID: 34356703]

Alex, S.; Tiwari, A. Functionalized gold nanoparticles: Synthesis, properties and applications-a review. J. Nanosci. Nanotechnol., 2015, 15(3), 1869-1894.
[http://dx.doi.org/10.1166/jnn.2015.9718] [PMID: 26413604]

Melaine, F.; Roupioz, Y.; Buhot, A. Gold nanoparticles surface plasmon resonance enhanced signal for the detection of small molecules on split-aptamer microarrays (small molecules detection from split-aptamers). Microarrays (Basel), 2015, 4(1), 41-52.
[http://dx.doi.org/10.3390/microarrays4010041] [PMID: 27600212]

Wang, Y.; Partridge, A.; Wu, Y. Improving nanoparticle-enhanced surface plasmon resonance detection of small molecules by reducing steric hindrance via molecular linkers. Talanta, 2019, 198, 350-357.
[http://dx.doi.org/10.1016/j.talanta.2019.02.035] [PMID: 30876572]

Cao, Y.; Griffith, B.; Bhomkar, P.; Wishart, D.S.; McDermott, M.T. Functionalized gold nanoparticle-enhanced competitive assay for sensitive small-molecule metabolite detection using surface plasmon resonance. Analyst (Lond.), 2018, 143(1), 289-296.
[http://dx.doi.org/10.1039/C7AN01680H] [PMID: 29184920]

Tagliavini, F.; Giaccone, G.; Frangione, B.; Bugiani, O. Preamyloid deposits in the cerebral cortex of patients with Alzheimer’s disease and nondemented individuals. Neurosci. Lett., 1988, 93(2-3), 191-196.
[http://dx.doi.org/10.1016/0304-3940(88)90080-8] [PMID: 3241644]

Masters, C.L.; Simms, G.; Weinman, N.A.; Multhaup, G.; McDonald, B.L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA, 1985, 82(12), 4245-4249.
[http://dx.doi.org/10.1073/pnas.82.12.4245] [PMID: 3159021]

Braak, H.; Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol., 1991, 82(4), 239-259.
[http://dx.doi.org/10.1007/BF00308809] [PMID: 1759558]

Thal, D.R.; Rüb, U.; Orantes, M.; Braak, H. Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology, 2002, 58(12), 1791-1800.
[http://dx.doi.org/10.1212/WNL.58.12.1791] [PMID: 12084879]

Hsiao, K.K.; Cass, C.; Schellenberg, G.D.; Bird, T.; Devine-Gage, E.; Wisniewski, H.; Prusiner, S.B. A prion protein variant in a family with the telencephalic form of Gerstmann-Straussler-Scheinker syndrome. Neurology, 1991, 41(5), 681-684.
[http://dx.doi.org/10.1212/WNL.41.5.681] [PMID: 1674116]

Ghetti, B.; Dlouhy, S.R.; Giaccone, G.; Bugiani, O.; Frangione, B.; Farlow, M.R.; Tagliavini, F. Gerstmann-Sträussler-Scheinker disease and the Indiana kindred. Brain Pathol., 1995, 5(1), 61-75.
[http://dx.doi.org/10.1111/j.1750-3639.1995.tb00578.x] [PMID: 7767492]

Goldfarb, L.G.; Brown, P.; McCombie, W.R.; Goldgaber, D.; Swergold, G.D.; Wills, P.R.; Cervenakova, L.; Baron, H.; Gibbs, C.J., Jr; Gajdusek, D.C. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc. Natl. Acad. Sci. USA, 1991, 88(23), 10926-10930.
[http://dx.doi.org/10.1073/pnas.88.23.10926] [PMID: 1683708]

Budka, H.; Aguzzi, A.; Brown, P.; Brucher, J.M.; Bugiani, O.; Gullotta, F.; Haltia, M.; Hauw, J.J.; Ironside, J.W.; Jellinger, K.; Kretzschmar, H.A.; Lantos, P.L.; Masullo, C.; Schlote, W.; Tateishi, J.; Weller, R.O. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol., 1995, 5(4), 459-466.
[http://dx.doi.org/10.1111/j.1750-3639.1995.tb00625.x] [PMID: 8974629]

McKee, A.C.; Stein, T.D.; Nowinski, C.J.; Stern, R.A.; Daneshvar, D.H.; Alvarez, V.E.; Lee, H.S.; Hall, G.; Wojtowicz, S.M.; Baugh, C.M.; Riley, D.O.; Kubilus, C.A.; Cormier, K.A.; Jacobs, M.A.; Martin, B.R.; Abraham, C.R.; Ikezu, T.; Reichard, R.R.; Wolozin, B.L.; Budson, A.E.; Goldstein, L.E.; Kowall, N.W.; Cantu, R.C. The spectrum of disease in chronic traumatic encephalopathy. Brain, 2013, 136(1), 43-64.
[http://dx.doi.org/10.1093/brain/aws307] [PMID: 23208308]

Crary, J.F.; Trojanowski, J.Q.; Schneider, J.A.; Abisambra, J.F.; Abner, E.L.; Alafuzoff, I.; Arnold, S.E.; Attems, J.; Beach, T.G.; Bigio, E.H.; Cairns, N.J.; Dickson, D.W.; Gearing, M.; Grinberg, L.T.; Hof, P.R.; Hyman, B.T.; Jellinger, K.; Jicha, G.A.; Kovacs, G.G.; Knopman, D.S.; Kofler, J.; Kukull, W.A.; Mackenzie, I.R.; Masliah, E.; McKee, A.; Montine, T.J.; Murray, M.E.; Neltner, J.H.; Santa-Maria, I.; Seeley, W.W.; Serrano-Pozo, A.; Shelanski, M.L.; Stein, T.; Takao, M.; Thal, D.R.; Toledo, J.B.; Troncoso, J.C.; Vonsattel, J.P.; White, C.L., III; Wisniewski, T.; Woltjer, R.L.; Yamada, M.; Nelson, P.T. Primary age-related tauopathy (PART): A common pathology associated with human aging. Acta Neuropathol., 2014, 128(6), 755-766.
[http://dx.doi.org/10.1007/s00401-014-1349-0] [PMID: 25348064]

Constantinidis, J.; Richard, J.; Tissot, R. Pick’s Disease. Eur. Neurol., 1974, 11(4), 208-217.
[http://dx.doi.org/10.1159/000114320] [PMID: 4137107]

Rebeiz, J.J.; Kolodny, E.H.; Richardson, E.P., Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch. Neurol., 1968, 18(1), 20-33.
[http://dx.doi.org/10.1001/archneur.1968.00470310034003] [PMID: 5634369]

Braak, H.; Tredici, K.D.; Rüb, U.; de Vos, R.A.I.; Jansen Steur, E.N.H.; Braak, E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging, 2003, 24(2), 197-211.
[http://dx.doi.org/10.1016/S0197-4580(02)00065-9] [PMID: 12498954]

McKinnon, S.J.; Lehman, D.M.; Kerrigan-Baumrind, L.A.; Merges, C.A.; Pease, M.E.; Kerrigan, D.F.; Ransom, N.L.; Tahzib, N.G.; Reitsamer, H.A.; Levkovitch-Verbin, H.; Quigley, H.A.; Zack, D.J. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest. Ophthalmol. Vis. Sci., 2002, 43(4), 1077-1087. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2200155
[PMID: 11923249]

Kasetti, R.B.; Patel, P.D.; Maddineni, P.; Patil, S.; Kiehlbauch, C.; Millar, J.C.; Searby, C.C.; Raghunathan, V.; Sheffield, V.C.; Zode, G.S. ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load. Nat. Commun., 2020, 11(1), 5594.
[http://dx.doi.org/10.1038/s41467-020-19352-1] [PMID: 33154371]

Kaushal, S.; Khorana, H.G. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry, 1994, 33(20), 6121-6128.
[http://dx.doi.org/10.1021/bi00186a011] [PMID: 8193125]

Regenmortel, M.H.V.; Choulier, L. Recognition of peptides by antibodies and investigations of affinity using biosensor technology. Comb. Chem. High Throughput Screen., 2001, 4(5), 385-395.
[http://dx.doi.org/10.2174/1386207013330940] [PMID: 11472227]

Jordan, C. E.; Frutos, A. G.; Thiel, A. J.; Corn, R. M. Surface plasmon resonance imaging measurements of dna hybridization adsorption and streptavidin/DNA multilayer formation at chemically modified gold surfaces. Anal. Chem., 1997, 69(24), 4939-4947.
[http://dx.doi.org/10.1021/ac9709763]

Danelian, E.; Karlén, A.; Karlsson, R.; Winiwarter, S.; Hansson, A.; Löfås, S.; Lennernäs, H.; Hämäläinen, M.D. SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: Correlation with fraction absorbed in humans. J. Med. Chem., 2000, 43(11), 2083-2086.
[http://dx.doi.org/10.1021/jm991156g] [PMID: 10841786]

Frostell-Karlsson, Å.; Remaeus, A.; Roos, H.; Andersson, K.; Borg, P.; Hämäläinen, M.; Karlsson, R. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. J. Med. Chem., 2000, 43(10), 1986-1992.
[http://dx.doi.org/10.1021/jm991174y] [PMID: 10821711]

Van Regenmortel, M.H.V. Analysing structure-function relationships with biosensors. Cell. Mol. Life Sci., 2001, 58(5), 794-800.
[http://dx.doi.org/10.1007/PL00000900] [PMID: 11437238]

Kaganer, E.; Pogreb, R.; Davidov, D.; Willner, I. Surfaceplasmon resonance characterization of photoswitchable antigen−antibody interactions. Langmuir, 1999, 15(11), 3920-3923.
[http://dx.doi.org/10.1021/la981147v]

Rosman, C.; Prasad, J.; Neiser, A.; Henkel, A.; Edgar, J.; Sönnichsen, C. Multiplexed plasmon sensor for rapid label-free analyte detection. Nano Lett., 2013, 13(7), 3243-3247.
[http://dx.doi.org/10.1021/nl401354f] [PMID: 23789876]

Jebelli, A.; Oroojalian, F.; Fathi, F.; Mokhtarzadeh, A.; Guardia, M. Recent advances in surface plasmon resonance biosensors for microRNAs detection. Biosens. Bioelectron., 2020, 169, 112599.
[http://dx.doi.org/10.1016/j.bios.2020.112599] [PMID: 32931990]

Bouguelia, S.; Roupioz, Y.; Slimani, S.; Mondani, L.; Casabona, M.G.; Durmort, C.; Vernet, T.; Calemczuk, R.; Livache, T. On-chip microbial culture for the specific detection of very low levels of bacteria. Lab Chip, 2013, 13(20), 4024-4032.
[http://dx.doi.org/10.1039/c3lc50473e] [PMID: 23912527]

Gorodkiewicz, E.; Ostrowska, H.; Sankiewicz, A. SPR imaging biosensor for the 20S proteasome: Sensor development and application to measurement of proteasomes in human blood plasma. Mikrochim. Acta, 2011, 175(1-2), 177-184.
[http://dx.doi.org/10.1007/s00604-011-0656-6] [PMID: 21966027]

Wang, Q.; Liu, Z. Recent progress of surface plasmon resonance in the development of coronavirus disease-2019 drug candidates. Eur. J. Med. Chem. Reports, 2021, 1, 100003.
[http://dx.doi.org/10.1016/j.ejmcr.2021.100003] [PMID: 36304139]